QRG Capital Management Inc. Decreases Position in HCA Healthcare, Inc. $HCA

QRG Capital Management Inc. lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 53.4% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 70,220 shares of the company’s stock after selling 80,483 shares during the quarter. QRG Capital Management Inc.’s holdings in HCA Healthcare were worth $29,928,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Park Place Capital Corp increased its stake in HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after acquiring an additional 1,168 shares during the last quarter. Cerity Partners LLC grew its stake in HCA Healthcare by 13.1% during the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after buying an additional 5,092 shares during the period. Swiss National Bank raised its stake in shares of HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after acquiring an additional 23,100 shares during the period. Cherokee Insurance Co acquired a new stake in HCA Healthcare in the 2nd quarter valued at $3,869,000. Finally, Harrell Investment Partners LLC boosted its position in shares of HCA Healthcare by 176.3% in the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after buying an additional 1,158 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 3.0%

Shares of HCA Healthcare stock opened at $469.08 on Friday. The stock has a market capitalization of $107.04 billion, a price-to-earnings ratio of 18.13, a PEG ratio of 1.33 and a beta of 1.36. The business’s 50 day simple moving average is $480.49 and its 200-day simple moving average is $430.45. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the business posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s payout ratio is currently 11.13%.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Leerink Partners raised its price target on HCA to $507 and kept an “outperform” rating, signaling analyst confidence in HCA’s earnings trajectory and providing a near-term valuation upside catalyst. Leerink Partners lifts price target on HCA Healthcare to $507
• Positive Sentiment: HCA plans to operate 81 freestanding emergency departments in Florida by the end of Q1, reflecting measurable expansion of outpatient / ED capacity that can drive admissions and higher-margin volumes. HCA to have 81 freestanding EDs in Florida by end of Q1
• Positive Sentiment: Regional partnership expansion in Tennessee positions HCA for market share and referral network growth in a fast-growing region. These deals support medium-term revenue expansion without full hospital acquisitions. Tennessee systems to deepen partnership as HCA eyes growth in region
• Neutral Sentiment: HCA promoted Erica Rossitto to chief nurse executive (effective Feb. 1), strengthening nursing leadership for HCA’s 100,000+ nurses — governance/operational news that supports execution but is not an immediate earnings driver. HCA Healthcare Names Erica Rossitto as Chief Nurse Executive
• Neutral Sentiment: Local executive moves (interim chief nurse at an HCA Missouri hospital and other chief nursing appointments) are operational-level items with limited near-term market impact. HCA Missouri hospital names interim chief nurse
• Neutral Sentiment: Third-party health-tech and regional care updates (Medical City Plano CFO change, Memorial Health CT adoption) mentioned in the newsfeed are industry context but not direct HCA drivers. Healthcare Briefs: Medical City Plano’s New CFO and Cariloop’s Partnership With Raymond James
• Negative Sentiment: L1 Capital trimmed its HCA position, citing share-price appreciation; portfolio selling from a notable fund can create near-term supply pressure and contribute to today’s down move. L1 Capital Trimmed HCA Healthcare Due to Share Price Appreciation

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on HCA shares. UBS Group raised their price target on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. Bank of America lifted their price objective on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Royal Bank Of Canada raised their price objective on shares of HCA Healthcare from $482.00 to $525.00 and gave the stock an “outperform” rating in a report on Friday, December 19th. Finally, TD Cowen lifted their price target on HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Fifteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $487.00.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.